U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083206) titled 'A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe' on July 16.
Brief Summary: The objective of this study is to evaluate the effectiveness and safety of Pitavastatin/Ezetimibe FDC in patients with hypercholesterolemia.
Study Start Date: July, 2025
Study Type: OBSERVATIONAL
Condition:
Hypercholesterolemia
Dyslipidemias
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd
Disclaimer: Curated by HT Syndication....